Birchview Capital, LP - 11 May 2022 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)

Role
10%+ Owner
Signature
Birchview Capital, LP By: /s/ Matthew Strobeck Matthew Strobeck, Managing Member of Birchview Capital GP, LLC, General Partner of Birchview Capital, LP
Issuer symbol
ELUT
Transactions as of
11 May 2022
Net transactions value
+$398,230
Form type
4
Filing time
13 Feb 2023, 18:01:15 UTC
Previous filing
13 Feb 2023
Next filing
27 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AZYO Class A Common Stock Purchase $1,192 +200 +0.01% $5.96 1,418,123 11 May 2022 See footnote F1, F2
transaction AZYO Class A Common Stock Purchase $190,000 +40,000 +2.8% $4.75 1,458,123 01 Dec 2022 See footnote F1, F2
transaction AZYO Class A Common Stock Purchase $35,800 +10,000 +0.69% $3.58 1,468,123 07 Dec 2022 See footnote F1, F2
transaction AZYO Class A Common Stock Purchase $121,720 +34,000 +2.3% $3.58 1,502,123 07 Dec 2022 See footnote F1, F3
transaction AZYO Class A Common Stock Purchase $34,377 +9,061 +0.6% $3.79 1,511,184 08 Dec 2022 See footnote F1, F3
transaction AZYO Class A Common Stock Purchase $15,141 +4,000 +0.26% $3.79 1,515,184 08 Dec 2022 See footnote F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC ("the Fund"). Birchview Capital, LP is the investment manager of the Fund.
F2 The Fund acquired the shares as specified in Table I. As investment manager of the Fund, Birchview Capital, LP possesses the power to vote and dispose or direct the disposition of the shares acquired by the Fund.
F3 As specified in Table I, Birchview Capital, LP advises the shares in a separately managed account ("SMA").
F4 As specified in Table I, Birchview Capital, LP advises the shares in a different SMA other than the one noted above.